Twist Bioscience Class Action Lawsuit TWST | Deadline February 10, 2023

Great news! On behalf of all investors who bought or otherwise acquired Twist Bioscience Corporation (Twist Bioscience Class Action Lawsuit) common stock between December 13, 2019, and November 14, 2022, inclusive, have the opportunity to join the TWST Lawsuit.

CLICK HERE FOR MORE DETAILS ABOUT THE TWST CLASS ACTION LAWSUIT

According to the TWST lawsuit, the defendants made the following statements throughout the Class Period and/or failed to disclose them:

1) Defendants allegedly overestimated the economic viability of Twist’s synthetic DNA manufacturing technology, according to the Scorpion Capital report from November 15, 2022; and

2) The defendants were utilizing unjustified pricing and accounting fraud to overstate the company’s actual financial situation and future prospects.

If you suffered a loss in TWST Lawsuit, you have until February 10, 2023, to request that the Court appoint you as the lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.